BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors.

Cancer Med · 2018 · PMC6198233 · PMID 30171671

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Furthermore, event‐free survival ( EFS )‐a (93.0% vs 84.8%; P = 0.068) and EFS ‐b (71.1% vs 57.9%; P = 0.061) by 5 years were also marginally significant.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.